Description

Our client is interested in selling their pharmaceutical business. The company has an FDA approved drug for radiation blocking. Current customers include the US and multiple Middle East governments. Sales have been strong given the constant threat of a nuclear plant accident, or a terrorist act. The company is highly profitable with 2015 EBITDA of USD 4,500,000 with little marketing effort. The product also has immense retail OTC, and online sales potential

Posted Mar 13, 2016

Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.

By clicking "Sign Up" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.

Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.